MIMEDX Announces Filing of Shelf Registration Statement with Securities and Exchange CommissionGlobeNewsWire • 08/27/21
Medicare Data: Significant Reductions in Amputations, Emergency Visits, and Hospital Readmissions Associated with Advanced Treatment Using Skin Substitute Products for Lower Extremity Diabetic Ulcers (LEDUs)GlobeNewsWire • 08/17/21
MIMEDX Promotes Marion Snyder to Chief of Staff, Senior Vice President, Government AffairsGlobeNewsWire • 08/12/21
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
NAACP to Present Historic Spingarn Medal to Regenerative Engineering Pioneer Cato T. Laurencin, M.D.GlobeNewsWire • 07/14/21
MIMEDX to Present at the Raymond James 2021 Human Health Innovation ConferenceGlobeNewsWire • 06/16/21
New Study Demonstrates Potential for MIMEDX Purion® Processed Dehydrated Human Amnion/Chorion Membrane to Modulate Pathological Scar Tissue FormationGlobeNewsWire • 06/15/21
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2021 Annual Meeting of ShareholdersGlobeNewsWire • 05/25/21
Prescience Point Announces Withdrawal of Its Slate of Nominees to MiMedx's BoardPRNewsWire • 05/04/21
MIMEDX Urges Shareholders to Consider Prescience Point's Motivations Before Voting Their Shares at the Company's Annual MeetingGlobeNewsWire • 05/04/21
MIMEDX Files Definitive Proxy Materials and Mails Letter to Shareholders Highlighting Actions Taken to Transform MIMEDX and Drive Significant Value for ShareholdersGlobeNewsWire • 05/03/21
MiMedx Group, Inc. (MDXG) CEO Tim Wright on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/29/21
MiMedx Welcomes Dirk Stevens, Ph.D., as Senior Vice President, Quality Assurance and Regulatory AffairsGlobeNewsWire • 04/28/21
MiMedx to Host First Quarter 2021 Operating and Financial Results Conference Call on April 29GlobeNewsWire • 04/22/21
MiMedx Announces Last Patients Last Visits in Three Late-Stage Musculoskeletal Trials with Proprietary Tissue TechnologyGlobeNewsWire • 04/19/21
MiMedx Confirms Receipt of Director Nominations from Prescience Point Capital ManagementGlobeNewsWire • 04/16/21
Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual MeetingPRNewsWire • 04/16/21
MiMedx Awarded Amniotic Tissue Supplier Agreement with Premier® Inc.'s SURPASS™ Purchasing ProgramGlobeNewsWire • 03/30/21